Key result
This paper describes the design of a multicenter prospective observational study to evaluate the clinical usefulness of semi-automatic flow-mediated vasodilatation measurement for cardiovascular risk stratification.
Why the study?
Does semi-automatic measurement of flow-mediated vasodilatation predict cardiovascular events and disease progression in Japanese subjects?
Observational (n=4,000)
Yes
Does semi-automatic measurement of flow-mediated vasodilatation predict cardiovascular events and disease progression in Japanese subjects?
Answers are grounded in this paper and cite their sources.
This study design outlines a multicenter prospective observational investigation to establish the clinical usefulness of semi-automatic FMD measurement for cardiovascular risk stratification in Japanese subjects.
Flow-mediated vasodilatation of the brachial artery (FMD) is a marker which is related to endothelial nitric oxide bioavailability. Commercially available ultrasound machines equipped with online computer-assisted semi-automatic analysis software to measure FMD have recently become available in Japan. These devices enable more convenient examination, enhanced reproducibility of FMD measurement, and a shortened examination time. Using such devices, in the present multicenter prospective study we propose to: 1) establish standardized FMD values and determine the annual rates of FMD change in healthy subjects; 2) confirm the predictive value of FMD for future cardiovascular events in Japanese subjects; 3) evaluate the potential usefulness of a multimarker strategy, including measurements of FMD, pulse-wave velocity (PWV), ankle-brachial pressure index, biochemical markers, and proteomic biomarkers obtained by mass spectroscopic analysis to assess the prognosis of subjects with coronary artery disease; and 4) clarify the usefulness of FMD measurement to predict the rate of progression of carotid atherosclerosis, arterial stiffness and microalbuminuria in subjects with hypertension or diabetes mellitus. In total, we estimate that approximately 4000 Japanese subjects in 3 different study groups will eventually be enrolled in this prospective observational investigation. We anticipate that the present study will provide important evidence for the usefulness of FMD measurement in the risk stratification for cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Tomiyama et al. (2012) conducted an observational in Cardiovascular disease risk stratification (n=4,000). Flow-mediated vasodilatation (FMD) measurement was evaluated on Composite of coronary artery restenosis or de novo coronary artery stenosis, and a composite of stroke, heart failure, and sudden death (for the CAD cohort). This paper describes the design of a multicenter prospective observational study to evaluate the clinical usefulness of semi-automatic flow-mediated vasodilatation measurement for cardiovascular risk stratification.
Synapse has enriched 10 related papers. Consider them for comparative context: